Improve the quality of ontologies in biopharma through the development and integration of an open application development platform by leveraging and enhancing the mobi ontology platform to enable…
Ended Cooperative Agreement Awarded Last action
- Award ID
- 70NANB23H262
- Recipient
-
Crown Point Technologies LLC UEI LECJUM4A7AB1
- Awarding agency
-
National Institute of Standards and Technology
Department of Commerce
- Obligated
- $159,538
Award facts
- Assistance listing
- 11.609 Measurement and Engineering Research and Standards
- Completion date
- Originally
- Place of performance
- Columbia, MD 21046, USA
Award details come from USAspending.gov.
Description
- Purpose
- The purpose of this grant is to improve the quality of ontologies in biopharma through the development and integration of an open application development platform by leveraging and enhancing the mobi ontology platform to enable improved data collaboration, governance, and integration within the industrial ontology foundry's ontology library.
- Activities
- The project will engage with the industrial ontology foundry architecture working group to deploy mobi and make IT accessible to the IOF community to support collaborative ontology development. The project will then develop and deploy enhancements to mobi addressing OWL syntax support and user experience improvements to enable the replacement of prot'g as the primary ontology editor for the IOF community. Finally, the project will deploy enhancements to mobi addressing reasoner integration, local ontology development support, and ontology hygiene and validation tools to improve ontology quality and advanced ontology engineering expected outcomes: the project will provide an open semantic development platform, the proposed research will accelerate the development and adoption of ontology standards for biopharmaceutical manufacturing.
- Intended beneficiaries
- An open semantic development platform is a powerful data-focused tool that offers substantial relevance and benefits to the general public by fostering collaboration, innovation, and efficiency throughout the ontological development process. By utilizing this approach, the biopharmaceutical manufacturing industry can reduce the time to market for new and generic drugs and develop a higher-quality product for less cost.
- Subrecipient activities
- The proposal does not include sub-awards.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $159,538 |
Quick answers
Who received award 70NANB23H262?
70NANB23H262 was awarded to Crown Point Technologies LLC by National Institute of Standards and Technology (Department of Commerce) on October 1, 2023.
How much is award 70NANB23H262 worth?
$159,538 has been obligated on 70NANB23H262.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award